Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | AMGN | BMY | GILD | VRTX |
| Company | Sangamo Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.8500 | 337.03 | 49.89 | 84.39 | 477.70 |
| High | 0.9400 | 338.70 | 50.04 | 84.65 | 483.98 |
| Low | 0.8431 | 334.61 | 48.94 | 83.43 | 476.27 |
| Last | 0.9000 | 335.95 | 49.02 | 83.90 | 477.90 |
| Change | +0.0629 | +3.03 | -0.72 | +0.01 | +3.74 |
| % Change | +7.51% | +0.91% | -1.45% | +0.01% | +0.79% |
| Volume | 5,005,452 | 1,626,123 | 8,839,651 | 8,797,902 | 939,786 |
| 20-Day Average Volume | 3,832,738 | 1,760,681 | 8,610,093 | 6,694,915 | 987,024 |
| Previous Close | 0.8371 | 332.92 | 49.74 | 83.89 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8273 | 329.59 | 49.09 | 80.07 | 479.86 |
| 20-Day Raw Stochastic | 76.98% | 84.75% | 55.24% | 89.62% | 43.50% |
| 20-Day Relative Strength | 56.34% | 57.67% | 54.18% | 71.87% | 49.36% |
| Weighted Alpha | -67.23 | +27.09 | -11.20 | +18.24 | +33.54 |
| Today's Opinion | 100% Buy | 96% Buy | 56% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 72% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.04% since 09/12/24 | +1.78% since 09/12/24 | +1.62% since 09/12/24 | +0.89% since 09/12/24 | -0.16% since 09/12/24 |
| Low | 0.8121 on 09/17/24 | 327.15 on 09/13/24 | 48.20 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 |
| High | 0.9400 on 09/19/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +4.41% since 08/19/24 | +2.43% since 08/19/24 | -0.57% since 08/19/24 | +12.69% since 08/19/24 | -2.08% since 08/19/24 |
| Low | 0.7000 on 09/09/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 |
| High | 0.9598 on 08/22/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +113.68% since 06/18/24 | +9.79% since 06/18/24 | +20.12% since 06/18/24 | +32.86% since 06/18/24 | +2.27% since 06/18/24 |
| Low | 0.3040 on 07/05/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 1.2500 on 08/06/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +16.88% since 03/19/24 | +23.63% since 03/19/24 | -5.37% since 03/19/24 | +14.29% since 03/19/24 | +15.10% since 03/19/24 |
| Low | 0.3040 on 07/05/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 1.2500 on 08/06/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 173,707 | 178,589,936 | 100,827,960 | 104,514,608 | 122,358,416 |
| Shares Outstanding, K | 207,510 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 176,230,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -257,830,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 360,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -36,130,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.23 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 08/06/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/06/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 36.12 | 17.67 | 0.00 |